Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

NCT05301322 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1471

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

BIOLOGICAL: RSVpreF Vaccine
OTHER: Placebo
BIOLOGICAL: Seasonal Inactivated Influenza Vaccine

Sponsor

Pfizer